Anti-Leukemic Attributes of Natural Compounds Targeting Autophagy: A Closer Look into the Molecular Mechanisms

References

• Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest. 2007;117(2):326–336. doi: 10.1172/JCI28833.
   PubMed Web of Science ®Google Scholar
• Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol. 2010;22(2):124–131. 10.1016/j.ceb.11.014.
   PubMed Web of Science ®Google Scholar
• Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy. 2018;14(2):207–215. doi: 10.1080/15548627.1378838.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay U, Kaushik S, Varticovski L, Cuervo AM. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane. Mol Cell Biol. 2008;28(18):5747–5763. doi: 10.1128/MCB.02070-07.
   PubMed Web of Science ®Google Scholar
• Wirawan E, Berghe TV, Lippens S, Agostinis P, Vandenabeele P. Autophagy: for better or for worse. Cell Res. 2012;22(1):43–61. doi: 10.1038/cr.2011.152.
   PubMed Web of Science ®Google Scholar
• Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014;20(3):460–473. 10.1089/ars.2013.5371.
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi: 10.1182/blood-2016-06-721662. 10.1182/blood-2016-03-643544
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Watts J, Nimer S. Recent advances in the understanding and treatment of acute myeloid leukemia. F1000Res. 2018;7:1196. doi: 10.12688/f1000research.14116.1.
   Google Scholar
• Salminen A, Kaarniranta K, Kauppinen A. Beclin 1 interactome controls the crosstalk between apoptosis, autophagy and inflammasome activation: impact on the aging process. Ageing Res Rev. 2013;12(2):520–534. doi: 10.1016/j.arr.2012.11.004.
   PubMed Web of Science ®Google Scholar
• Yun CW, Lee SH. The roles of autophagy in cancer. Int J Mol Sci. 2018;19(11):3466. doi: 10.3390/ijms19113466.
   PubMed Web of Science ®Google Scholar
• Mathew R, Khor S, Hackett SR, Rabinowitz JD, Perlman DH, White E. Functional role of autophagy-mediated proteome remodeling in cell survival signaling and innate immunity. Mol Cell. doi: 2014;55(6):916–930. 10.1016/j.molcel.2014.07.019.
   PubMed Web of Science ®Google Scholar
• Hayashi-Nishino M, Fujita N, Noda T, Yamaguchi A, Yoshimori T, Yamamoto A. A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat Cell Biol. 2009;11(12):1433–1437. doi: 10.1038/ncb1991.
   PubMed Web of Science ®Google Scholar
• Ylä-Anttila P, Vihinen H, Jokitalo E, Eskelinen E-L. 3D tomography reveals connections between the phagophore and endoplasmic reticulum. Autophagy. 2009;5(8):1180–1185. doi: 10.4161/auto.5.8.10274.
   PubMed Web of Science ®Google Scholar
• Alers S, Löffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol. 2012;32(1):2–11. doi: 10.1128/MCB.06159-11.
   PubMed Web of Science ®Google Scholar
• Pópulo H, Lopes JM, Soares P. The mTOR signalling pathway in human cancer. Int J Mol Sci. 2012;13(2):1886–1918. doi: 10.3390/ijms13021886.
   PubMed Web of Science ®Google Scholar
• Kim YC, Guan K-L. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest. 2015;125(1):25–32. doi: 10.1172/JCI73939.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, Guan K-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141. doi: 10.1038/ncb2152.
   PubMed Web of Science ®Google Scholar
• Axe EL, Walker SA, Manifava M, Chandra P, Roderick HL, Habermann A, Griffiths G, Ktistakis NT. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol. 2008;182(4):685–701. doi: 10.1083/jcb.200803137.
   PubMed Web of Science ®Google Scholar
• Ganley IG, Lam DH, Wang J, Ding X, Chen S, Jiang X. ULK1·ATG13·FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem. 2009;284(18):12297–12305. doi: 10.1074/jbc.M900573200.
   PubMed Web of Science ®Google Scholar
• Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et al. Nutrient-dependent mTORC1 association with the ULK1–Atg13–FIP200 complex required for autophagy. Mol Biol Cell. 2009;20(7):1981–1991. doi: 10.1091/mbc.e08-12-1248.
   PubMed Web of Science ®Google Scholar
• Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402(6762):672–676. doi: 10.1038/45257.
   PubMed Web of Science ®Google Scholar
• Itakura E, Mizushima N. Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins. Autophagy. 2010;6(6):764–776. doi: 10.4161/auto.6.6.12709.
   PubMed Web of Science ®Google Scholar
• Furuya N, Yu J, Byfield M, Pattingre S, Levine B. The evolutionarily conserved domain of beclin 1 is required for Vps34 binding, autophagy, and tumor suppressor function. Autophagy. 2005;1(1):46–52. doi: 10.4161/auto.1.1.1542.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Akioka M, Kondo-Kakuta C, Yamamoto H, Ohsumi Y. Fine mapping of autophagy-related proteins during autophagosome formation in Saccharomyces cerevisiae. J Cell Sci. 2013;126(Pt 11):2534–2544. doi: 10.1242/jcs.122960.
   PubMed Web of Science ®Google Scholar
• Wijdeven RH, Janssen H, Nahidiazar L, Janssen L, Jalink K, Berlin I, Neefjes J. Cholesterol and ORP1L-mediated ER contact sites control autophagosome transport and fusion with the endocytic pathway. Nat Commun. 2016;7(1):11808. doi: 10.1038/ncomms11808.
   PubMedGoogle Scholar
• Guo JY, Xia B, White E. Autophagy-mediated tumor promotion. Cell. 2013;155(6):1216–1219. doi: 10.1016/j.cell.2013.11.019.
   PubMed Web of Science ®Google Scholar
• Barnard RA, Regan DP, Hansen RJ, Maycotte P, Thorburn A, Gustafson DL. Autophagy inhibition delays early but not late-stage metastatic disease. J Pharmacol Exp Ther. 2016;358(2):282–293. doi: 10.1124/jpet.116.233908.
   PubMed Web of Science ®Google Scholar
• White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer. 2012;12(6):401–410. doi: 10.1038/nrc3262.
   PubMed Web of Science ®Google Scholar
• Baquero P, Dawson A, Mukhopadhyay A, Kuntz EM, Mitchell R, Olivares O, Ianniciello A, Scott MT, Dunn K, Nicastri MC, et al. Targeting quiescent leukemic stem cells using second generation autophagy inhibitors. Leukemia. 2019;33(4):981–994. doi: 10.1038/s41375-018-0252-4.
   PubMed Web of Science ®Google Scholar
• Watson A, Riffelmacher T, Stranks A, Williams O, De Boer J, Cain K, MacFarlane M, McGouran J, Kessler B, Khandwala S, et al. Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia. Cell Death Discov. 2015;1(1):15008. doi: 10.1038/cddiscovery.2015.8.
   PubMedGoogle Scholar
• Yamamoto H, Zhang S, Mizushima N. Autophagy genes in biology and disease. Nat Rev Genet. 2023;24(6):382–400. doi: 10.1038/s41576-022-00562-w.
   PubMed Web of Science ®Google Scholar
• Nurjanah N, Saepudin E. Curcumin isolation, synthesis and characterization of curcumin isoxazole derivative compound. Depok, Indonesia, 2019. p. 020065. doi: 10.1063/1.5132492
   Google Scholar
• 1.PubChem CID 96951. https://pubchem.ncbi.nlm.nih.gov/compound/969516#section=2D-Structure.
   Google Scholar
• Surh Y-J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003;3(10):768–780. doi: 10.1038/nrc1189.
   PubMed Web of Science ®Google Scholar
• Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets. 2011;12(3):332–347. doi: 10.2174/138945011794815356
   PubMed Web of Science ®Google Scholar
• Elgizawy HA, Ali AA, Hussein MA. Resveratrol: isolation, and its nanostructured lipid carriers, inhibits cell proliferation, induces cell apoptosis in certain human cell lines carcinoma and exerts protective effect against paraquat-induced hepatotoxicity. J Med Food. 2021;24(1):89–100. doi: 10.1089/jmf.2019.0286.
   PubMed Web of Science ®Google Scholar
• PubChem CID 445154. https://pubchem.ncbi.nlm.nih.gov/compound/445154#section=2D-Structure.
   Google Scholar
• Kulkarni SS, Cantó C. The molecular targets of resveratrol. Biochim Biophys Acta. 2015;1852(6):1114–1123. doi: 10.1016/j.bbadis.2014.10.005.
   PubMed Web of Science ®Google Scholar
• Lee A-R, Wu W-L, Chang W-L, Lin H-C, King M-L. Isolation and bioactivity of new tanshinones. J Nat Prod. 1987;50(2):157–160. doi: 10.1021/np50050a004.
   PubMed Web of Science ®Google Scholar
• PubChem CID 164676. https://pubchem.ncbi.nlm.nih.gov/compound/164676#section=2D-Structure.
   Google Scholar
• Fang Z, Zhang M, Liu J, Zhao X, Zhang Y, Fang L. Tanshinone IIA: a review of its anticancer effects. Front Pharmacol. 2020;11:611087. doi: 10.3389/fphar.2020.611087.
   PubMed Web of Science ®Google Scholar
• Liu H, Liu C, Wang M, Sun D, Zhu P, Zhang P, Tan X, Shi G. Tanshinone IIA affects the malignant growth of cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway. Sci Rep. 2021;11(1):19268. doi: 10.1038/s41598-021-98948-z.
   PubMed Web of Science ®Google Scholar
• Das S, Das MK, Das R, Gehlot V, Mahant S, Mazumder PM, Das S, Falls N, Kumar V. Isolation, characterization of berberine from Berberis aristata DC for eradication of resistant Helicobacter pylori. Biocatal Agric Biotechnol. 2020;26:101622. doi: 10.1016/j.bcab.2020.101622.
   Web of Science ®Google Scholar
• PubChem CID 2353. https://pubchem.ncbi.nlm.nih.gov/compound/2353#section=2D-Structure.
   Google Scholar
• Guo P, Cai C, Wu X, Fan X, Huang W, Zhou J, Wu Q, Huang Y, Zhao W, Zhang F, et al. An insight into the molecular mechanism of berberine towards multiple cancer types through systems pharmacology. Front Pharmacol. 2019;10:857. doi: 10.3389/fphar.2019.00857.
   PubMed Web of Science ®Google Scholar
• Huang XY, Wang Y, De Lu Z. Isolation and preparation of 3H-tetrandrine. Labelled Comp Radiopharmac. 1994;34(10):899–903. doi: 10.1002/jlcr.2580341002.
   Web of Science ®Google Scholar
• PubChem CID 73078. https://pubchem.ncbi.nlm.nih.gov/compound/73078#section=2D-Structure.
   Google Scholar
• Luan F, He X, Zeng N. Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems. J Pharm Pharmacol. 2020;72(11):1491–1512. doi: 10.1111/jphp.13339.
   PubMed Web of Science ®Google Scholar
• Čretnik L, Škerget M, Knez Ž. Separation of parthenolide from feverfew: performance of conventional and high-pressure extraction techniques. Sep Purif Technol. 2005;41(1):13–20. doi: 10.1016/j.seppur.2004.03.011.
   Web of Science ®Google Scholar
• PubChem CID 7251185. https://pubchem.ncbi.nlm.nih.gov/compound/7251185#section=2D-Structure.
   Google Scholar
• Freund RRA, Gobrecht P, Fischer D, Arndt H-D. Advances in chemistry and bioactivity of parthenolide. Nat Prod Rep. 2020;37(4):541–565. doi: 10.1039/C9NP00049F.
   PubMed Web of Science ®Google Scholar
• Sanghavi N, Srivastava R, Malode Y. Isolation and identification of the flavonoid “quercetin” from tridax procumbens linn. Int J Pharm Sci Res. 2014;5:1454–1459. doi: 10.13040/IJPSR.0975-8232.5(4).1454-59.
   Google Scholar
• PubChem CID 5280343. https://pubchem.ncbi.nlm.nih.gov/compound/5280343#section=2D-Structure.
   Google Scholar
• Vafadar A, Shabaninejad Z, Movahedpour A, Fallahi F, Taghavipour M, Ghasemi Y, Akbari M, Shafiee A, Hajighadimi S, Moradizarmehri S, et al. Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells. Cell Biosci. 2020;10(1):32. doi: 10.1186/s13578-020-00397-0.
   PubMed Web of Science ®Google Scholar
• Khalid SA, Tahir AE, Satti GM, Friedrichsen GM, Christensen SB. Isolation and characterization of pristimerin as the antiplasmodial and antileishmanial agent of Maytenus senegalensis (Lam.) Exell. Arkivoc. 2007;2007(9):129–134. doi: 10.3998/ark.5550190.0008.915.
   Google Scholar
• PubChem CID 159516. https://pubchem.ncbi.nlm.nih.gov/compound/159516#section=2D-Structure.
   Google Scholar
• Chen R-Z, Yang F, Zhang M, Sun Z-G, Zhang N. Cellular and molecular mechanisms of pristimerin in cancer therapy: recent advances. Front Oncol. 2021;11:671548. doi: 10.3389/fonc.2021.671548.
   PubMed Web of Science ®Google Scholar
• Trendafilova A, Chanev C, Todorova M. Ultrasound-assisted extraction of alantolactone and isoalantolactone from Inula helenium roots. Pharmacogn Mag. 2010;6(23):234–237. doi: 10.4103/0973-1296.66942.
   PubMed Web of Science ®Google Scholar
• PubChem CID 72724. https://pubchem.ncbi.nlm.nih.gov/compound/72724#section=2D-Structure.
   Google Scholar
• Babaei G, Gholizadeh-Ghaleh Aziz S, Rajabi Bazl M, Khadem Ansari MH. A comprehensive review of anticancer mechanisms of action of alantolactone. Biomed Pharmacother. 2021;136:111231. doi: 10.1016/j.biopha.2021.111231.
   PubMed Web of Science ®Google Scholar
• Sadria M, Seo D, Layton AT. The mixed blessing of AMPK signaling in cancer treatments. BMC Cancer. 2022;22(1):105. 10.1186/s12885-022-09211-1.
   PubMed Web of Science ®Google Scholar
• Looi W, Zargari A, Dun K, Grigoriadis G, Fedele P, Gregory GP, Low MSY. Concomitant diagnosis of chronic myeloid leukemia and myeloma. Pathology. 2022;54(4):493–495. doi: 10.1016/j.pathol.2021.08.007.
   PubMed Web of Science ®Google Scholar
• Yun S, Vincelette ND, Segar JM, Dong Y, Shen Y, Kim D-W, Abraham I. Comparative effectiveness of newer tyrosine kinase inhibitors versus imatinib in the first-line treatment of chronic-phase chronic myeloid leukemia across risk groups: a systematic review and meta-analysis of eight randomized trials. Clin Lymphoma Myeloma Leuk. 2016;16(6):e85–e94. doi: 10.1016/j.clml.2016.03.003.
   PubMed Web of Science ®Google Scholar
• Paramasivam M, Poi R, Banerjee H, Bandyopadhyay A. High-performance thin layer chromatographic method for quantitative determination of curcuminoids in Curcuma longa germplasm. Food Chem. 2009;113(2):640–644. doi: 10.1016/j.foodchem.2008.07.051.
   Web of Science ®Google Scholar
• Jia Y-L, Li J, Qin Z-H, Liang Z-Q. Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. J Asian Nat Prod Res. 2009;11(11):918–928. doi: 10.1080/10286020903264077.
   PubMed Web of Science ®Google Scholar
• Rainey N, Motte L, Aggarwal BB, Petit PX. Curcumin hormesis mediates a cross-talk between autophagy and cell death. Cell Death Dis. 2015;6(12):e2003. doi: 10.1038/cddis.2015.343.
   PubMedGoogle Scholar
• Puissant A, Robert G, Fenouille N, Luciano F, Cassuto J-P, Raynaud S, Auberger P. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res. 2010;70(3):1042–1052. doi: 10.1158/0008-5472.CAN-09-3537.
   PubMed Web of Science ®Google Scholar
• Li J, Guo Q, Lei X, Zhang L, Su C, Liu Y, Zhou W, Chen H, Wang H, Wang F, et al. Pristimerin induces apoptosis and inhibits proliferation, migration in H1299 lung cancer cells. J Cancer. 2020;11(21):6348–6355. doi: 10.7150/jca.44431.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ren Z, Li X, Zhong J, Bi Y, Li R, Zhao Q, Yu X. Pristimerin induces autophagy-mediated cell death in K562 cells through the ROS/JNK signaling pathway. Chem Biodivers. 2019;16(8):e1900325. doi: 10.1002/cbdv.201900325.
   PubMed Web of Science ®Google Scholar
• Lu Z, Jin Y, Chen C, Li J, Cao Q, Pan J. Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl. Mol Cancer. 2010;9(1):112. doi: 10.1186/1476-4598-9-112.
   Google Scholar
• Ming Q, Han T, Li W, Zhang Q, Zhang H, Zheng C, Huang F, Rahman K, Qin L. Tanshinone IIA and tanshinone I production by Trichoderma atroviride D16, an endophytic fungus in Salvia miltiorrhiza. Phytomedicine. 2012;19(3–4):330–333. doi: 10.1016/j.phymed.2011.09.076.
   PubMed Web of Science ®Google Scholar
• Yun S-M, Jung JH, Jeong S-J, Sohn EJ, Kim B, Kim S-H. Tanshinone IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cells: tanshinone IIA induces autophagic cell death in KBM-5 cells. Phytother Res. 2014;28(3):458–464. doi: 10.1002/ptr.5015.
   PubMed Web of Science ®Google Scholar
• Van Vlierberghe P, Van Grotel M, Beverloo HB, Lee C, Helgason T, Buijs-Gladdines J, Passier M, Van Wering ER, Veerman AJP, Kamps WA, et al. The cryptic chromosomal deletion, del(11)(p12p13), as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood. 2006;108(11):220. doi: 10.1182/blood.V108.11.220.220.
   Web of Science ®Google Scholar
• Zelent A, Greaves M, Enver T. Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukemia. Oncogene. 2004;23(24):4275–4283. doi: 10.1038/sj.onc.1207672.
   PubMed Web of Science ®Google Scholar
• Shi C, Lan W, Wang Z, Yang D, Wei J, Liu Z, Teng Y, Gu M, Yuan T, Cao F, et al. Alantolactone inhibits cell autophagy and promotes apoptosis via AP2M1 in acute lymphoblastic leukemia. Cancer Cell Int. 2020;20(1):442. doi: 10.1186/s12935-020-01537-9.
   PubMed Web of Science ®Google Scholar
• Karthikeyan R, Devadasu C, Srinivasa Babu P. Isolation, characterization, and RP-HPLC estimation of P-coumaric acid from methanolic extract of Durva Grass (Cynodon dactylon Linn.) (Pers.). Int J Anal Chem. 2015;2015:201386–201387. doi: 10.1155/2015/201386.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu P, Xu T, Chen Z, Kong H, Chu W, Wang Y, Liu Y. Berberine induces autophagic cell death in acute lymphoblastic leukemia by inactivating AKT/mTORC1 signaling. Drug Des Dev Ther. 2020;14:1813–23. doi: 10.2147/DDDT.S239247.
   PubMed Web of Science ®Google Scholar
• Siedlecka-Kroplewska K, Wozniak M, Kmiec Z. The wine polyphenol resveratrol modulates autophagy and induces apoptosis in MOLT-4 and HL-60 human leukemia cells. J Physiol Pharmacol. 2019;70:825–838. doi: 10.26402/jpp.2019.6.02.
   Web of Science ®Google Scholar
• Harikumar KB, Kunnumakkara AB, Sethi G, Diagaradjane P, Anand P, Pandey MK, Gelovani J, Krishnan S, Guha S, Aggarwal BB, et al. Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer. 2010;127(2):257–268. doi: 10.1002/ijc.25041.
   PubMed Web of Science ®Google Scholar
• Grimwade D, Ivey A, Huntly BJP. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood. 2016;127(1):29–41. doi: 10.1182/blood-2015-07-604496.
   PubMed Web of Science ®Google Scholar
• Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, Dombret H, Ebert BL, Fenaux P, Larson RA, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447. doi: 10.1182/blood-2016-08-733196.
   PubMed Web of Science ®Google Scholar
• Steele AJ, Jones DT, Ganeshaguru K, Duke VM, Yogashangary BC, North JM, Lowdell MW, Kottaridis PD, Mehta AB, Prentice AG, et al. The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia. 2006;20(6):1073–1079. doi: 10.1038/sj.leu.2404230.
   PubMed Web of Science ®Google Scholar
• Lan B, Wan Y-J, Pan S, Wang Y, Yang Y, Leng Q-L, Jia H, Liu Y-H, Zhang C-Z, Cao Y, et al. Parthenolide induces autophagy via the depletion of 4E-BP1. Biochem Biophys Res Commun. 2015;456(1):434–439. doi: 10.1016/j.bbrc.2014.11.102.
   PubMed Web of Science ®Google Scholar
• Itoh T, Ohguchi K, Nozawa Y, Akao Y. Intracellular glutathione regulates sesquiterpene lactone-induced conversion of autophagy to apoptosis in human leukemia HL60 cells. Anticancer Res. 2009;29(4):1449–1457.
   PubMed Web of Science ®Google Scholar
• Xiao J, Zhang B, Yin S, Xie S, Huang K, Wang J, Yang W, Liu H, Zhang G, Liu X, et al. Quercetin induces autophagy-associated death in HL-60 cells through CaMKKβ/AMPK/mTOR signal pathway. ABBS. 2022;54(9):1244–1256. doi: 10.3724/abbs.2022117.
   Google Scholar
• Fang Y, Zhang Q, Yuan X, Lv C, Zhang J, Zhu Y, Wei Z, Xia Y, Dai Y. Tetrandrine, an immunosuppressive alkaloid isolated from Steohania tetrandra S. Moore, induces the generation of Treg cells through enhancing fatty acid oxidation. Immunology. 2022;166(4):492–506. doi: 10.1111/imm.13500.
   PubMed Web of Science ®Google Scholar
• Wang J, Yao Z, Lai X, Bao H, Li Y, Li S, Chang L, Zhang G. Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway. Cancer Med. 2020;9(19):7268–7278. doi: 10.1002/cam4.3356.
   PubMed Web of Science ®Google Scholar
• Liu T, Men Q, Wu G, Yu C, Huang Z, Liu X, Li W. Tetrandrine induces autophagy and differentiation by activating ROS and Notch1 signaling in leukemia cells. Oncotarget. 2015;6(10):7992–8006. doi: 10.18632/oncotarget.3505.
   PubMedGoogle Scholar
• Pan Y, Chen L, Li R, Liu Y, Nan M, Hou L. Tanshinone IIA induces autophagy and apoptosis via PI3K/Akt/mTOR axis in acute promyelocytic leukemia NB4 cells. Evid Based Complement Alternat Med. 2021;2021:3372403–3372409. doi: 10.1155/2021/3372403.
   PubMed Web of Science ®Google Scholar
• Zhou X, Xu Z, Li A, Zhang Z, Xu S. Double-sides sticking mechanism of vinblastine interacting with α,β-tubulin to get activity against cancer cells. J Biomol Struct Dyn. 2019;37(15):4080–4091. doi: 10.1080/07391102.2018.1539412.
   PubMed Web of Science ®Google Scholar